TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
Go back to TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 200.05 +0.09 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.96 | 52 Week High | $333.65 | |||
| Open | $200.57 | 52 Week Low | $223.02 | |||
| Day High | $203.45 | P/E | 25.61 | |||
| Day Low | $199.06 | EPS | $7.81 | |||
| Volume | 837,294 | |||||
